Newsletter: The Road to Recovery
Expert coverage of how the business and economy are recovering after the pandemic. Delivered 3 times a week.
The Biden administration’s plan for an extensive booster program is that the advisory board of the highest public health agencies provides a third dose only to the elderly and those with underlying health and works in high-risk jobs. Another blow was given to those who were exposed to Covid-19 because it was recommended not to provide it.
The Vaccine Commission, which advises the US Centers for Disease Control and Prevention, recommends boosters of the BioNTech / Pfizer vaccine for people over the age of 65 and home caregivers, with 13-2 adding to the underlying people aged 50-64. It was unanimously approved to approve the vaccination. Medical condition.
The Commission cast 9-6 votes to provide boosters to people over the age of 18 with underlying health. According to CDC data, this group consists of at least 50 million people. However, the panel rejected the approval of the third jab for people working in jobs at high risk of exposure to Covid, with 9-6 votes.
Biden administration plan Start an extensive program for all Americans over the age of 16 starting next week, even before regulatory approvals. It offended some scientists, retirement Two top FDA executives earlier this month
The FDA’s advisory board then refused to recommend the BioNTech / Pfizer booster to anyone over the age of 16 and instead recommended a more limited group of older, at-risk individuals. The FDA took note of the recommendation on Wednesday. Approval A third dose to people over the age of 65 and adults at high risk for severe Covid-19, or adults whose work is frequently exposed to the virus.
After some members asked if the need for additional doses outweighed the potential risks, the CDC Panel recommended a narrower set of qualifications. Rare heart-related side effectsEspecially for young people.
Helen Talbot, associate professor at Vanderbilt University, said:
“I don’t think there is data for these younger age groups to determine booster doses,” she added.
The third vaccination will only be available to those who first received the BioNTech / Pfizer jab 6 months after the full vaccination. Some scientists questioned the logistics and fairness of this and complained about the lack of data on single-dose Johnson & Johnson vaccine boosters.
“I don’t know what I can say to people over the age of 65.” You are at serious risk of hospitalization. .. .. But for now, only half of you can protect yourself, “said Sarah Long, a pediatric professor at Drexel University School of Medicine.
Scientists continue to prioritize complete vaccination, defined as a second dose of mRNA jab, such as that produced by BioNTech / Pfizer and Moderna, or two weeks after a single J & J shot. I paid attention to it. The FDA has already approved a third dose of mRNA vaccine for people with weakened immune systems.
The group discussed the extent to which people can assess their eligibility because boosters can be provided based on human language.This causes some people to Sneak booster Before the official recommendation.
“If you don’t give it flexibility, you’re robbing these patients in need of something that can save lives,” said Sandra Freihofer, head of the American Medical Association.
Some members questioned the range of data available. Camille Cotton, an infectious disease specialist at Massachusetts General Hospital, said blacks and Latin people under the age of 65 were dead and needed more data to reflect their ethnicity. “It’s not the same result across all racial groups,” she said.
The CDC panel supports BioNTech / Pfizer boosters for seniors and risky groups
Source link The CDC panel supports BioNTech / Pfizer boosters for seniors and risky groups
The post The CDC panel supports BioNTech / Pfizer boosters for seniors and risky groups appeared first on Eminetra.